A deficient pyruvate kinase with an electrophoretically slow-moving component

Area of Science:

• Biochemistry
• Hematology
• Genetics

Background:

• Congenital non-spherocytic anemia (CNSA) is a group of inherited red blood cell disorders.
• Erythrocyte pyruvate kinase (EPK) deficiency is a known cause of CNSA, leading to impaired glycolysis.
• Understanding EPK variants is crucial for diagnosing and managing hemolytic anemias.

Purpose of the Study:

• To characterize the biochemical and biophysical properties of a deficient EPK variant found in a patient with CNSA.
• To investigate the molecular basis of EPK deficiency in the affected individual.

Main Methods:

• Enzyme activity assays on patient hemolysates.
• Analysis of enzyme kinetics, including substrate and inhibitor interactions (PEP, FDP, ATP, ADP).
• Assessment of enzyme stability (thermal and urea denaturation).
• Electrophoretic analysis (isoelectric focusing or polyacrylamide gel electrophoresis) to detect enzyme heterogeneity.

Main Results:

• The patient's EPK exhibited significantly reduced activity in hemolysates.
• The deficient EPK showed decreased thermal stability and slightly increased urea denaturation.
• Kinetic analysis revealed high affinity for phosphoenolpyruvate (PEP) and decreased affinity for ADP.
• Poor activation by fructose-1,6-bisphosphate (FDP) was observed, while ATP inhibition remained normal.
• Electrophoresis identified an abnormal, slow-moving EPK component, suggesting enzyme heterogeneity.

Conclusions:

• The characterized EPK deficiency in the patient presented with multiple altered enzymatic properties.
• The findings suggest the patient is likely double heterozygous for two different deficient EPK mutants.
• This genetic combination likely underlies the observed congenital non-spherocytic anemia.